BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37567517)

  • 21. Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism.
    Fan CY; Pan J; Usuda N; Yeldandi AV; Rao MS; Reddy JK
    J Biol Chem; 1998 Jun; 273(25):15639-45. PubMed ID: 9624157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of peroxisome proliferator-activated receptor alpha, and PPARalpha regulated genes in spontaneously developed hepatocellular carcinomas in fatty acyl-CoA oxidase null mice.
    Meyer K; Jia Y; Cao WQ; Kashireddy P; Rao MS
    Int J Oncol; 2002 Dec; 21(6):1175-80. PubMed ID: 12429965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of WY-14643 on peroxisomal enzyme activity and hormone secretion in immortalized human trophoblast cells.
    Hashimoto F; Morita M; Iwasaki K; Takeda S; Hayashi H
    Biol Pharm Bull; 2009 Jul; 32(7):1278-82. PubMed ID: 19571398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver-specific Nrf2 deficiency accelerates ethanol-induced lethality and hepatic injury in vivo.
    Sun J; Hong Z; Shao S; Li L; Yang B; Hou Y; Wang H; Xu Y; Zhang Q; Pi J; Fu J
    Toxicol Appl Pharmacol; 2021 Sep; 426():115617. PubMed ID: 34116071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated basal expression of liver peroxisomal beta-oxidation enzymes and CYP4A microsomal fatty acid omega-hydroxylase in STAT5b(-/-) mice: cross-talk in vivo between peroxisome proliferator-activated receptor and signal transducer and activator of transcription signaling pathways.
    Zhou YC; Davey HW; McLachlan MJ; Xie T; Waxman DJ
    Toxicol Appl Pharmacol; 2002 Jul; 182(1):1-10. PubMed ID: 12127257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic Treatment With WY-14643 Induces Tumorigenesis and Triglyceride Accumulation in Mouse Livers.
    Yang J; Fan S; Zhang Y; Huang M; Gao Y; Bi H
    Drug Metab Dispos; 2022 Dec; 50(12):1464-1471. PubMed ID: 36184081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-alpha (PPARalpha)-regulated genes and is ameliorated by PPARalpha activation.
    Nanji AA; Dannenberg AJ; Jokelainen K; Bass NM
    J Pharmacol Exp Ther; 2004 Jul; 310(1):417-24. PubMed ID: 15016835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice.
    Ip E; Farrell GC; Robertson G; Hall P; Kirsch R; Leclercq I
    Hepatology; 2003 Jul; 38(1):123-32. PubMed ID: 12829994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmenter of liver regeneration protein deficiency promotes hepatic steatosis by inducing oxidative stress and microRNA-540 expression.
    Kumar S; Rani R; Karns R; Gandhi CR
    FASEB J; 2019 Mar; 33(3):3825-3840. PubMed ID: 30540918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome proliferator-activated receptor alpha-responsive genes induced in the newborn but not prenatal liver of peroxisomal fatty acyl-CoA oxidase null mice.
    Cook WS; Jain S; Jia Y; Cao WQ; Yeldandi AV; Reddy JK; Rao MS
    Exp Cell Res; 2001 Aug; 268(1):70-6. PubMed ID: 11461119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of L-carnitine against oxidative stress in human hepatocytes: involvement of peroxisome proliferator-activated receptor alpha.
    Li JL; Wang QY; Luan HY; Kang ZC; Wang CB
    J Biomed Sci; 2012 Mar; 19(1):32. PubMed ID: 22435679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time course investigation of PPARalpha- and Kupffer cell-dependent effects of WY-14,643 in mouse liver using microarray gene expression.
    Woods CG; Kosyk O; Bradford BU; Ross PK; Burns AM; Cunningham ML; Qu P; Ibrahim JG; Rusyn I
    Toxicol Appl Pharmacol; 2007 Dec; 225(3):267-77. PubMed ID: 17950772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-interference of two model peroxisome proliferators in peroxisomal and estrogenic pathways in brown trout hepatocytes.
    Madureira TV; Pinheiro I; Malhão F; Lopes C; Urbatzka R; Castro LFC; Rocha E
    Aquat Toxicol; 2017 Jun; 187():153-162. PubMed ID: 28415051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the species-specificity of peroxisome proliferators in rat and human hepatocytes.
    Ammerschlaeger M; Beigel J; Klein KU; Mueller SO
    Toxicol Sci; 2004 Apr; 78(2):229-40. PubMed ID: 14976357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR.
    Rosen MB; Lee JS; Ren H; Vallanat B; Liu J; Waalkes MP; Abbott BD; Lau C; Corton JC
    Toxicol Sci; 2008 May; 103(1):46-56. PubMed ID: 18281256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice.
    Fischer M; You M; Matsumoto M; Crabb DW
    J Biol Chem; 2003 Jul; 278(30):27997-8004. PubMed ID: 12791698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis.
    Cherkaoui-Malki M; Meyer K; Cao WQ; Latruffe N; Yeldandi AV; Rao MS; Bradfield CA; Reddy JK
    Gene Expr; 2001; 9(6):291-304. PubMed ID: 11764000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PPARalpha activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes.
    Edvardsson U; Ljungberg A; Lindén D; William-Olsson L; Peilot-Sjögren H; Ahnmark A; Oscarsson J
    J Lipid Res; 2006 Feb; 47(2):329-40. PubMed ID: 16282640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxic effects of fumonisin in mouse liver are independent of the peroxisome proliferator-activated receptor alpha.
    Voss KA; Liu J; Anderson SP; Dunn C; Miller JD; Owen JR; Riley RT; Bacon CW; Corton JC
    Toxicol Sci; 2006 Jan; 89(1):108-19. PubMed ID: 16221962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between fatty acid oxidation and ethanol metabolism in liver.
    Lu Y; George J
    Am J Physiol Gastrointest Liver Physiol; 2024 May; 326(5):G483-G494. PubMed ID: 38573193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.